IGC PHARMA, INC.: 10-Q filed 2012-02-16

Name: IGC PHARMA, INC.: 10-Q filed 2012-02-16
Creator: IGC PHARMA, INC.

What IGC PHARMA, INC. reported in its quarterly report filed 2012-02-16 (fiscal Q3 2011): 38 published measures, 90 facts as tagged in accession 0001185185-12-000256.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-02-16
Fiscal period: fiscal Q3 2011
Accession: 0001185185-12-000256 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IGC PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-12-31	35,098,619	USD
At 2011-03-31	18,162,069	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-12-31	17,936,766	USD
At 2011-03-31	7,786,826	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-12-31	13,014,008	USD
At 2011-03-31	6,666,306	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-12-31	4,444,972	USD
At 2011-03-31	1,583,284	USD
At 2010-12-31	1,470,191	USD
At 2010-03-31	842,923	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,901,375	USD	92
2011-04-01 to 2011-12-31	-3,559,831	USD	275
2010-04-01 to 2011-03-31	-20,240,907	USD	365
2010-10-01 to 2010-12-31	-1,749,018	USD	92
2010-04-01 to 2010-12-31	-3,196,453	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	-1,198,618	USD	275
2010-04-01 to 2010-12-31	-2,206,667	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	986,799	USD	92
2011-04-01 to 2011-12-31	2,959,167	USD	275
2010-10-01 to 2010-12-31	484,106	USD	92
2010-04-01 to 2010-12-31	3,294,103	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	8,201	USD	275
2010-04-01 to 2010-12-31	2,823,586	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	4,229,538	USD	275
2010-04-01 to 2010-12-31	8,538	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-12-31	-33,252,738	USD
At 2011-03-31	-29,692,907	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2010-10-01 to 2010-12-31	-20,212	USD	92
2010-04-01 to 2010-12-31	-475,226	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-12-31	8,021,606	USD
At 2011-03-31	1,231,761	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	235,267	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,049,268	USD	92
2011-04-01 to 2011-12-31	-2,467,113	USD	275
2010-10-01 to 2010-12-31	-1,489,794	USD	92
2010-04-01 to 2010-12-31	-2,817,914	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-12-31	14,563,434	USD
At 2011-03-31	6,545,164	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	174,353	USD	92
2011-04-01 to 2011-12-31	624,086	USD	275
2010-10-01 to 2010-12-31	307,630	USD	92
2010-04-01 to 2010-12-31	718,339	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-12-31	12,952,846	USD
At 2011-03-31	6,577,347	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-12-31	998,560	USD
At 2011-03-31	1,311,963	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2011-12-31	952,836	USD
At 2011-03-31	410,454	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2011-12-31	5,971,786	USD
At 2011-03-31	3,312,051	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-12-31	767,432	USD
At 2011-03-31	133,539	USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	1,024,817	USD	92
2011-04-01 to 2011-12-31	2,902,650	USD	275
2010-10-01 to 2010-12-31	457,379	USD	92
2010-04-01 to 2010-12-31	3,053,512	USD	275

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	968,890	USD	92
2011-04-01 to 2011-12-31	2,354,405	USD	275
2010-10-01 to 2010-12-31	1,054,894	USD	92
2010-04-01 to 2010-12-31	2,399,503	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-12-31	47,591,843	shares
At 2011-03-31	14,890,181	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-12-31	48,887,101	USD
At 2011-03-31	38,860,319	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-12-31	-2,625,115	USD
At 2011-03-31	-2,502,596	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2011-12-31	14,079,469	USD
At 2011-03-31	7,292,859	USD
At 2010-03-31	26,153,460	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2011-12-31	3,880,957	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-12-31	246,863	USD
At 2011-03-31	748,623	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-12-31	4,270,023	USD
At 2011-03-31	1,209,479	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-12-31	1,316,012	USD
At 2011-03-31	349,149	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-12-31	3,097,845	USD
At 2011-03-31	1,474,838	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,913,944	USD	92
2011-04-01 to 2011-12-31	-3,583,115	USD	275
2010-10-01 to 2010-12-31	-1,762,469	USD	92
2010-04-01 to 2010-12-31	-3,212,467	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	169,225	USD	275
2010-04-01 to 2010-12-31	659,002	USD	275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2010-04-01 to 2010-12-31	-449,635	USD	275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2010-04-01 to 2010-12-31	3,001,118	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	748,522	USD	275
2010-04-01 to 2010-12-31	-674,956	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	54,309	USD	275
2010-04-01 to 2010-12-31	-169,100	USD	275

Inspect the source

Entity: IGC PHARMA, INC. / CIK 0001326205
Captured: 2026-09-19T11:17:33.392Z
SEC response SHA-256: b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))